Alpha Growth plc

("Alpha", or the "Company")

Interim Results

Alpha Growth plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class, is pleased to announce its results for the interim period ended 28 February 2019.

Highlights:

·    Approval by the BVI FSC of the acquisition of Alpha Longevity Management Limited ("ALM")

·    Acquisition of Colva Insurance Services ("Colva") to increase valuation and actuarial resource as we ramp up

·    Appointment of Rajiv Rebello as Chief Actuary and Jason Sutherland as Non-Executive Director

·    The joint venture with SL for the soon to be launched fund.

Gobind Sahney, Chairman of Alpha, commented:

"The Group really is well positioned now to get some serious traction in 2019. With the imminent launch of the recently announced Fund and the other engagements we have at various stages of completion; the Board and I are very excited about our prospects for the remainder of 2019 and beyond. We have taken a number of large steps in the last six months and we hope to be announcing further developments over the coming months."

The full Interims results for the period ended 28 February 2019, can be found on the Company's website: http://algwplc.com.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For more information, please visit www.algwplc.com or contact the following:

About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide wholistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.